UCB wins FDA approval for seizure drug
Keppra XR is expected to be available in US pharmacies at the end of September 2008. The goal of therapy with antiepileptic drugs is freedom from seizures and

Keppra XR is expected to be available in US pharmacies at the end of September 2008. The goal of therapy with antiepileptic drugs is freedom from seizures and

Advanced Medical Institute (AMI) will conduct its business in the UK through its wholly-owned subsidiary, AMI Clinic Limited (AVMD UK). AMI has opened its first two UK clinics

Enrollment is expected to begin at six US medical institutions by the end of 2008. The objective of the trial is to evaluate the safety and efficacy of

The generic formulation compares to Taro’s referenced listed drug and is available in three sizes: 15g tubes, 30g tubes and 45g tubes. David Klaum, senior vice president and

Net proceeds are expected to be approximately $4.1 million after offering-related fees and expenses. Catalyst intends to use the proceeds from the offering to fund certain required non-clinical

The Omnilux product line – Omnilux Blue, Omnilux Plus and Omnilux Revive – provide physicians with new choices for the treatment of acne, ocular wrinkles, wound therapy and

The effects of AC-100 on cartilage regeneration were evaluated in goats with standardized medial femoral condylar (knee cartilage) defects. In one study, deep defects in knee cartilage and

Ms Poon began her career with Johnson & Johnson in November, 2000, as company group chairman of pharmaceuticals. Ms Poon was later appointed worldwide chairman, Medicines & Nutritionals,

Steven Rash has resigned as CEO and chairman of Power3. Mr Rash’s employment ceased on September 3, 2008, as did his service as a director of the company.

The first is a license and development agreement for the two companies to jointly develop a surgical stapling device which will attach to Intuitive’s da Vinci surgical systems